ALBERTDAVD

Albert David Limited

Allopathic and herbal pharmaceutical formulations under Kothari group

Healthcare›Healthcare›Pharmaceuticals & Biotechnology›Pharmaceuticals

albertdavidindia.com(opens the company website in a new tab)
Ask AI

Key metrics

Price as of 2026-10-16

Stock price
₹831.00
Market cap
474 Cr
Stock P/E
21.0
P/B
1.21
Dividend yield
0.6%
ROE (FY26)
-0.4%
ROCE (FY26)
0.8%
Operating margin (FY26)
-1.3%
Debt / equity (FY26)
0.07
OCF / EBITDA (3Y)
17.0%

Full years shown; sign in free for the trailing twelve months. Learn about these metrics →

Price & valuation

Share price and valuation multiples (P/E, P/B and more) over time.

Loading price history…

Compare with peers

Loading peers…

What you need to know

Albert David makes allopathic and herbal formulations and intravenous (I.V.) infusions, selling in India and exporting to Latin America, South East Asia and a few North African countries.

Company snapshot

99thBy market cap

Ranked among 119 companies in Pharmaceuticals.

What we see

Positives
  • ✓Debt-to-equity of 0.07x — the company is largely funded by its own money, not borrowed funds.
Concerns
  • ✗Net margin is negative — the company is spending more than it earns right now.
3 more signals from the filings.Sign in free to see them all

Statement tables · Standalone

Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.

Standalone only

Amounts in ₹ Cr · tap + to expand rows

Quarterly results

Quarterly · ₹ Cr · tap + rows to expand

MetricSept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Sales93 Cr88 Cr89 Cr89 Cr98 Cr83 Cr75 Cr71 Cr87 Cr90 Cr86 Cr101 Cr
Operating expenses (approx.)77 Cr80 Cr79 Cr88 Cr92 Cr82 Cr80 Cr81 Cr85 Cr79 Cr83 Cr91 Cr
EBITDA16 Cr8 Cr10 Cr0.88 Cr6 Cr0.67 Cr-5 Cr-11 Cr3 Cr11 Cr3 Cr11 Cr
OPM %17.1%9.5%10.7%1.0%6.3%0.8%-6.3%-15.1%2.9%12.0%3.2%10.5%
Other income12 Cr17 Cr10 Cr23 Cr21 Cr-9 Cr-5 Cr22 Cr-2 Cr12 Cr-25 Cr28 Cr
Interest0.06 Cr0.12 Cr0.07 Cr0.09 Cr0.06 Cr0.13 Cr0.13 Cr0.55 Cr0.75 Cr0.90 Cr0.43 Cr0.52 Cr
Depreciation1 Cr2 Cr2 Cr2 Cr2 Cr2 Cr2 Cr2 Cr2 Cr2 Cr3 Cr2 Cr
Profit before tax27 Cr23 Cr18 Cr22 Cr25 Cr-10 Cr-12 Cr8 Cr-3 Cr20 Cr-25 Cr36 Cr
Tax %23.5%20.1%28.7%14.6%28.1%7.6%12.5%5.9%-27.9%23.1%15.1%10.6%
Net profit20 Cr19 Cr13 Cr19 Cr18 Cr-9 Cr-10 Cr8 Cr-3 Cr15 Cr-21 Cr32 Cr
EPS (₹)₹35.57₹32.80₹22.63₹33.02₹31.67₹-16.45₹-18.10₹13.91₹-5.79₹26.81₹-37.56₹56.07

Profit & loss (annual)

Annual · last column is TTM · ₹ Cr · tap + to expand

MetricMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales306 Cr289 Cr317 Cr321 Cr247 Cr314 Cr342 Cr362 Cr346 Cr334 CrSign in free for the trailing twelve months
Operating expenses (approx.)279 Cr267 Cr287 Cr290 Cr228 Cr273 Cr297 Cr316 Cr343 Cr328 CrSign in free for the trailing twelve months
EBITDA28 Cr22 Cr30 Cr30 Cr19 Cr41 Cr44 Cr47 Cr3 Cr5 CrSign in free for the trailing twelve months
OPM %9.1%7.5%9.4%9.4%7.7%13.0%13.0%12.9%0.9%1.6%Sign in free for the trailing twelve months
Other income8 Cr9 Cr7 Cr7 Cr17 Cr16 Cr15 Cr58 Cr30 Cr7 CrSign in free for the trailing twelve months
Interest0.74 Cr0.86 Cr0.62 Cr0.80 Cr0.65 Cr0.53 Cr0.46 Cr0.32 Cr0.41 Cr3 CrSign in free for the trailing twelve months
Depreciation8 Cr8 Cr7 Cr8 Cr8 Cr9 Cr9 Cr7 Cr7 Cr10 CrSign in free for the trailing twelve months
Profit before tax27 Cr22 Cr43 Cr29 Cr27 Cr47 Cr51 Cr97 Cr25 Cr0.52 CrSign in free for the trailing twelve months
Tax %37.4%37.4%37.8%33.8%19.3%25.5%28.7%22.5%31.8%384.8%Sign in free for the trailing twelve months
Net profit16 Cr10 Cr27 Cr19 Cr22 Cr35 Cr36 Cr75 Cr17 Cr-1 CrSign in free for the trailing twelve months
EPS (₹)₹27.96₹17.24₹46.68₹33.59₹38.80₹61.78₹63.39₹132.15₹30.14₹-2.62Sign in free for the trailing twelve months
Dividend payout %————0.2%9.7%14.2%6.9%1.4%—Sign in free for the trailing twelve months
Sign in free for the trailing twelve months

The latest four quarters added up, next to each full year

Balance sheet

Annual · ₹ Cr · tap + rows to expand

MetricMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity capital6 Cr6 Cr6 Cr6 Cr6 Cr6 Cr6 Cr6 Cr6 Cr6 Cr
Reserves177 Cr180 Cr205 Cr217 Cr239 Cr274 Cr306 Cr377 Cr387 Cr386 Cr
Borrowings30 Cr28 Cr0.44 Cr1 Cr0.83 Cr5 Cr5 Cr2 Cr10 Cr28 Cr
Other liabilities71 Cr76 Cr85 Cr96 Cr96 Cr118 Cr107 Cr113 Cr109 Cr99 Cr
Total liabilities285 Cr289 Cr295 Cr320 Cr341 Cr403 Cr423 Cr498 Cr511 Cr519 Cr
Fixed assets (net)87 Cr83 Cr77 Cr89 Cr82 Cr84 Cr78 Cr82 Cr98 Cr99 Cr
CWIP7 Cr3 Cr3 Cr2 Cr0.75 Cr0.81 Cr3 Cr7 Cr2 Cr21 Cr
Investments59 Cr68 Cr113 Cr122 Cr138 Cr183 Cr193 Cr273 Cr261 Cr247 Cr
Loans & advances——15 Cr14 Cr13 Cr5 Cr9 Cr4 Cr4 Cr2 Cr
Inventories51 Cr43 Cr44 Cr43 Cr36 Cr39 Cr51 Cr44 Cr64 Cr58 Cr
Trade receivables33 Cr27 Cr23 Cr30 Cr19 Cr25 Cr30 Cr29 Cr27 Cr34 Cr
Cash & bank15 Cr25 Cr7 Cr6 Cr5 Cr2 Cr1 Cr5 Cr0.42 Cr0.30 Cr
Other assets34 Cr40 Cr15 Cr15 Cr47 Cr63 Cr59 Cr54 Cr55 Cr58 Cr
Total assets285 Cr289 Cr295 Cr320 Cr341 Cr403 Cr423 Cr498 Cr511 Cr519 Cr

Cash flows

Annual · ₹ Cr · tap + rows to expand · last column includes FCF

MetricMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from operating activity20 Cr30 Cr32 Cr30 Cr37 Cr40 Cr11 Cr46 Cr-28 Cr-8 Cr
Cash from investing-37 Cr-11 Cr-19 Cr-20 Cr-37 Cr-40 Cr-5 Cr-33 Cr23 Cr-4 Cr
Cash from financing7 Cr-5 Cr-17 Cr-10 Cr-2 Cr-5 Cr-6 Cr-8 Cr0.11 Cr12 Cr
Net cash flow-10 Cr14 Cr-4 Cr-0.08 Cr-2 Cr-4 Cr-0.83 Cr4 Cr-5 Cr-0.12 Cr
Free cash flow (OCF − Capex)-0.20 Cr26 Cr30 Cr15 Cr35 Cr29 Cr5 Cr35 Cr-43 Cr-37 Cr

Ratios

MetricMar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
ROCE %13.1%10.5%20.6%13.3%11.5%16.8%16.2%25.3%6.4%0.8%
ROE %8.7%5.3%12.7%8.6%9.1%12.6%11.6%19.7%4.4%-0.4%
Debtor days39342634292932302937
Inventory days294267272278354277290249332354
Days payable159196204259316219184194195198
Cash conversion cycle1751059453668713985166194
OCF / EBITDA %71.3%138.1%107.8%99.3%191.2%98.9%23.7%97.1%n.m.n.m.
OCF / EBITDA % (3 years)——103.3%112.7%124.7%118.6%83.9%73.0%29.3%17.0%
Debt / equity0.160.150.00210.00650.00340.020.020.00550.030.07
Current ratio1.861.932.692.482.772.333.073.753.403.24
Net debt / EBITDA0.560.10-0.22-0.16-0.220.060.09-0.073.185.15